We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Procter & Gamble Company (PG - Free Report) , popularly known as P&G, reported first-quarter fiscal 2020 results, wherein the top and bottom lines surpassed the Zacks Consensus Estimate. This marked the company’s 18th straight earnings beat. Earnings and sales also improved on a year-over-year basis. Moreover, the company raised its guidance for fiscal 2020.
Procter & Gamble’s core earnings of $1.37 per share improved 22% year over year and outpaced the Zacks Consensus Estimate of $1.24. Meanwhile, currency-neutral core earnings per share (EPS) grew 24%.
Procter & Gamble Company (The) Price, Consensus and EPS Surprise
The solid quarterly outcome boosted investor sentiment. Evidently, the stock gained almost 4.4% during the pre-market trading session. We note that shares of the Zacks Rank #3 (Hold) company have grown 36.6% in the past year, outperforming the industry’s 21.7% rally.
Sales in Detail
Procter & Gamble reported net sales of $17,798 million, beating the Zacks Consensus Estimate of $17,465 million and improving 6.6% year over year. However, the top line was hurt by currency fluctuations of about 2%.
Organically (excluding the impact of acquisitions, divestitures and foreign exchange), revenues grew 7%, driven by 4% rise in organic shipment volume. Further, organic sales benefited 1% from increased pricing and 2% from favorable mix. Strong Personal Health Care, and Skin and Personal Care categories along with robust gains in Japan mainly aided the company’s mix. Notably, all of these have higher than average selling prices.
Moreover, all of the company’s business segments reported organic sales growth. Organic sales improved 10% for the Beauty segment, 9% for Health Care, 8% for Fabric & Home Care, 5% for Baby, Feminine and Family Care, and 1% for the Grooming segment.
Net sales at Beauty, Health Care, Fabric & Home Care, and Baby, Feminine and Family Care segments grew 8%, 20%, 6% and 4%, respectively. Meanwhile, sales declined 1% for the Grooming segment.
Margins
In the reported quarter, core gross margin increased 190 basis points (bps) year over year to 51.3%, including nearly 10 bps of adverse impact of foreign currency. On a currency-neutral basis, core gross margin expanded 200 bps, backed by gains from productivity savings, higher pricing, commodity cost declines, fixed cost leverage and other benefits. This uptick was partly offset by unfavorable product mix.
Core selling, general and administrative expenses (SG&A), as a percentage of sales, declined 70 bps to 27%. Currency-neutral core SG&A costs decreased 60 bps, driven by savings from overhead and marketing expenses, and gains from sales leverage. This was partly negated by marketing investments as well as inflation and other impacts like augmented digital investments and incentive compensation costs.
Moreover, core and currency-neutral operating margin expanded 260 bps to 24.3%, driven by 160 bps of total productivity cost savings.
Financials
Procter & Gamble ended the reported quarter with cash and cash equivalents of $9,304 million, long-term debt of $20,161 million, and total shareholders’ equity of $46,984 million.
Cash flow from operating activities amounted to $4,169 million for the fiscal first quarter, while adjusted free cash flow productivity was 91%. Furthermore, the company returned nearly $4.9 billion of cash to its shareholders. This included dividend payments worth $1.9 billion and share buybacks of roughly $3 billion.
For fiscal 2020, the company increased its view for adjusted free cash flow productivity to 95% from 90% stated earlier. It anticipates paying out more than $7.5 billion in dividends and repurchasing $6-$8 billion of common shares in fiscal 2020.
Fiscal 2020 Guidance
Driven by strong top-line growth, margin expansion and cash productivity witnessed in the fiscal first quarter, Procter & Gamble raised its view for fiscal 2020. The company now projects all-in and organic sales growth of 3-5% compared with 3-4% mentioned earlier. The guidance includes a modest impact of adverse foreign currency, which is likely to be mostly offset by slight gain from acquisitions and divestitures.
Moreover, the company now projects core EPS growth of 5-10% for fiscal 2020 compared with 4-9% mentioned earlier. In fiscal 2019, it reported core earnings of $4.52 per share.
Avon Products, Inc , also a Zacks Rank #2 stock, has an expected long-term earnings growth rate of 7.5%.
Helen of Troy Limited (HELE - Free Report) presently has a Zacks Rank #2 and an expected long-term earnings growth rate of 7.6%.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.50% per year. So be sure to give these hand-picked 7 your immediate attention.
Image: Bigstock
Procter & Gamble (PG) Stock Rises on Q1 Earnings & Sales Beat
The Procter & Gamble Company (PG - Free Report) , popularly known as P&G, reported first-quarter fiscal 2020 results, wherein the top and bottom lines surpassed the Zacks Consensus Estimate. This marked the company’s 18th straight earnings beat. Earnings and sales also improved on a year-over-year basis. Moreover, the company raised its guidance for fiscal 2020.
Procter & Gamble’s core earnings of $1.37 per share improved 22% year over year and outpaced the Zacks Consensus Estimate of $1.24. Meanwhile, currency-neutral core earnings per share (EPS) grew 24%.
Procter & Gamble Company (The) Price, Consensus and EPS Surprise
Procter & Gamble Company (The) price-consensus-eps-surprise-chart | Procter & Gamble Company (The) Quote
The solid quarterly outcome boosted investor sentiment. Evidently, the stock gained almost 4.4% during the pre-market trading session. We note that shares of the Zacks Rank #3 (Hold) company have grown 36.6% in the past year, outperforming the industry’s 21.7% rally.
Sales in Detail
Procter & Gamble reported net sales of $17,798 million, beating the Zacks Consensus Estimate of $17,465 million and improving 6.6% year over year. However, the top line was hurt by currency fluctuations of about 2%.
Organically (excluding the impact of acquisitions, divestitures and foreign exchange), revenues grew 7%, driven by 4% rise in organic shipment volume. Further, organic sales benefited 1% from increased pricing and 2% from favorable mix. Strong Personal Health Care, and Skin and Personal Care categories along with robust gains in Japan mainly aided the company’s mix. Notably, all of these have higher than average selling prices.
Moreover, all of the company’s business segments reported organic sales growth. Organic sales improved 10% for the Beauty segment, 9% for Health Care, 8% for Fabric & Home Care, 5% for Baby, Feminine and Family Care, and 1% for the Grooming segment.
Net sales at Beauty, Health Care, Fabric & Home Care, and Baby, Feminine and Family Care segments grew 8%, 20%, 6% and 4%, respectively. Meanwhile, sales declined 1% for the Grooming segment.
Margins
In the reported quarter, core gross margin increased 190 basis points (bps) year over year to 51.3%, including nearly 10 bps of adverse impact of foreign currency. On a currency-neutral basis, core gross margin expanded 200 bps, backed by gains from productivity savings, higher pricing, commodity cost declines, fixed cost leverage and other benefits. This uptick was partly offset by unfavorable product mix.
Core selling, general and administrative expenses (SG&A), as a percentage of sales, declined 70 bps to 27%. Currency-neutral core SG&A costs decreased 60 bps, driven by savings from overhead and marketing expenses, and gains from sales leverage. This was partly negated by marketing investments as well as inflation and other impacts like augmented digital investments and incentive compensation costs.
Moreover, core and currency-neutral operating margin expanded 260 bps to 24.3%, driven by 160 bps of total productivity cost savings.
Financials
Procter & Gamble ended the reported quarter with cash and cash equivalents of $9,304 million, long-term debt of $20,161 million, and total shareholders’ equity of $46,984 million.
Cash flow from operating activities amounted to $4,169 million for the fiscal first quarter, while adjusted free cash flow productivity was 91%. Furthermore, the company returned nearly $4.9 billion of cash to its shareholders. This included dividend payments worth $1.9 billion and share buybacks of roughly $3 billion.
For fiscal 2020, the company increased its view for adjusted free cash flow productivity to 95% from 90% stated earlier. It anticipates paying out more than $7.5 billion in dividends and repurchasing $6-$8 billion of common shares in fiscal 2020.
Fiscal 2020 Guidance
Driven by strong top-line growth, margin expansion and cash productivity witnessed in the fiscal first quarter, Procter & Gamble raised its view for fiscal 2020. The company now projects all-in and organic sales growth of 3-5% compared with 3-4% mentioned earlier. The guidance includes a modest impact of adverse foreign currency, which is likely to be mostly offset by slight gain from acquisitions and divestitures.
Moreover, the company now projects core EPS growth of 5-10% for fiscal 2020 compared with 4-9% mentioned earlier. In fiscal 2019, it reported core earnings of $4.52 per share.
3 Better-Ranked Stocks to Watch
Church & Dwight Co., Inc (CHD - Free Report) has an expected long-term earnings growth rate of 8.8%. It currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Avon Products, Inc , also a Zacks Rank #2 stock, has an expected long-term earnings growth rate of 7.5%.
Helen of Troy Limited (HELE - Free Report) presently has a Zacks Rank #2 and an expected long-term earnings growth rate of 7.6%.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.50% per year. So be sure to give these hand-picked 7 your immediate attention.
See them now >>